VEIL.AI

Today we are concluding an outstanding PHEMS consortium meeting! This day included a tour of the Great Ormond Street Hospital for Children NHS Foundation Trust premises and provided great insights into communication practices and interdependencies within the different PHEMS functions. VEIL.AI together with Erasmus MC held a workshop about metrics to compare models created with synthetic data against models developed from real world data. The workshop demonstrated the complexities of anonymization and synthetization and the critical role that synthetic data plays in PHEMS. A big thank you to Bruno Robalo and Brian van Winden from Erasmus MC for their hard work and cooperation in putting this workshop together. We would also like to extend a heartfelt thank you to the event organizers at GOSH DRIVE and HUS Helsingin yliopistollinen sairaala as well as all participants for their contributions to the success of this event. We look forward to continuing collaboration with all partners. #phems #crossborder #datasharing #datacollaboration #dataanonymization #datasynthetization #pediatricinnovation

Today was the first official day of the PHEMS consortium meeting. VEIL.AI CTO Timo Miettinen hosted a workshop on privacy enhancing technologies remotely. This presentation was targeted towards the entire consortium and the objective was to introduce the concepts of anonymization and synthetization, their advantages and uses as well as the relevance of these technologies to the PHEMS project. The day also featured multiple informative presentations lead by other PHEMS partners for example on the PHEMS terminology, federated node and analytics as well as OHDSI OMOP. Overall, the first day has provided a deep dive into the PHEMS use cases as well as the main concepts surrounding PHEMS. Meeting with the project partners in person has provoked astute discussions and offered valuables takes on the technical execution of the project. The insights gathered during the meeting will certainly be of help in the next phase to ensure a practical design and successful implementation of the anonymization and synthetization processes. Looking forward to the second day! #phems #crossborder #datasharing #datacollaboration #dataanonymization #datasynthetization

This week VEIL.AI is present as a key technology partner at the PHEMS project consortium meeting hosted at the GOSH DRIVE Office in London on June 18-19. We have partnered with pediatric hospitals and technology companies across Europe to enable transborder data collaborations of sensitive health data for research 🌍 The PHEMS project presents an innovative approach to managing pediatric health data. It aims to enhance cross-border collaboration, improve healthcare outcomes, and pave the way for a more integrated and efficient healthcare system in Europe. PHEMS strives to facilitate easier access to health data, thereby advancing federated health data analysis and creating services for generating shareable synthetic datasets. This project is particularly focused on addressing the challenges posed by privacy concerns and the complexity of data sharing due to varying interpretations of the EU General Data Protection Regulation (GDPR) and the upcoming European Health Data Space (EHDS). To address these privacy concerns, VEIL.AI’s next-generation anonymization comes into place with its unique capabilities to provide high-quality, individual-level, GDPR-compliant anonymized data. Our patented technology enables cross-border data sharing in compliance with regulations in PHEMS — all without compromising data quality. With years of experience in data anonymization and data-intensive projects, we have been helping customers unlock the full potential of sensitive health data while safeguarding privacy. CEO Tuomo Pentikäinen, Data Scientist for Customer Projects Susanne Hultsch, PhD and Senior Project Manager Anniina Wäyrynen from our team are present at the consortium meeting this week. We look forward to getting together and having face-to-face discussions with other key partners of the PHEMS project such as HUS Helsingin yliopistollinen sairaala, Great Ormond Street Hospital for Children NHS Foundation Trust, Erasmus MC, Barcelona Children's Hospital Sant Joan de Déu, Tietoevry, GENESIS Biomed, Aridhia – Digital Research Environment – DRE, The Hyve, Meyer Children’s Hospital IRCCS (MEYER) and Bērnu klīniskā universitātes slimnīca (Children’s University Hospital Latvia). Thank you to Gary Zhen Yuan Liew, MRPharmS and the team at GOSH as well as to Marja Vaitinen from HUS for arranging this consortium meeting! #phems #crossborder #datasharing #datacollaboration #dataanonymization #datasynthetization

📢 VEIL.AI is participating as a sponsor in the Organization for Organisation of European Cancer Institutes (OECI) 46th Oncology Days in Helsinki June 12-14th! OECI is a non-governmental organization comprised of 139 member institutes, including some of the most prominent European Comprehensive cancer centers. The focus of this year’s Oncology Days is on new cutting-edge technology in cancer treatment and in fighting inequalities in cancer research and care. The 46th OECI Oncology Days is hosted by the HUS Helsingin yliopistollinen sairaala (Helsinki University Hospital) Comprehensive Cancer Centre, the first accredited Comprehensive Cancer Center in the Nordics and the second in Europe. HUS is a key partner for VEIL.AI, where we aim to enable the development of cancer research and treatment with our next-generation anonymization services. CEO Tuomo Pentikäinen, Chief Business Development Officer Juha Paakkola, Chief Commercial Officer Kari Lehtipuu and CEO Danmark Lauri Kuronen will be at our booth to answer all of your questions related to the secondary use of health data, next-generation anonymization, and European Health Data Space (EHDS) in the next couple of days!

VEIL.AI participated as a sponsor in the 5th Nordic Conference on Pediatric Medicines on May 14-15th in Helsinki, Finland, alongside Bristol Myers Squibb, FVR - Suomen rokotetutkimus / Finnish Vaccine Research , ICON plc, MedEngine, and Tietoevry. VEIL.AI was highlighted by several keynote speakers, including Katariina Gehrmann (née Silander) of HUS Helsingin yliopistollinen sairaala New Children’s Hospital on the second day of the conference, where she discussed the novel PHEMS project. VEIL.AI is a key partner in this collaboration between European pediatric hospitals, where next-generation anonymization and synthetic data capabilities will allow researchers to access larger sets of sensitive pediatric health data. Read the news here 👉 https://lnkd.in/dnetVA3p #dataanonymization #syntheticdata #healthdata #pediatrichealth #clinicaltrial

In the ”Future Clinical Trials”, VEIL.AI helped Bayer to anonymize the data with such a high quality that one could draw the same conclusions from the anonymized data as from the traditional pseudonymized individual-level research data. In addition, Findata – Sosiaali- ja terveysalan tietolupaviranomainen | Social and Health Data Permit Authority gave the consent to export the anonymous data from their secure IT environment to Bayer’s secure environment in Germany! #dataanonymization #ehds #clinicaltrials #externalcontrolarms #realworlddata

Today we are wrapping up a fantastic WISDOM Project Kick-Off Event! The day has provided great insights into the Multiple Sclerosis, Rheumatoid Arthiritis and Myasthenia Gravis databases as well as relevant EU regulation, notably the European Health Data Space (EHDS). WP2 lead Saarela Janna, Research Director at Institute for Molecular Medicine Finland (FIMM), held a presentation and led the discussion regarding the work package, enabling us to attain a more comprehensive understanding of the available data. The thorough discussions and collaborative spirit have set the stage for great advancements in the management of chronic immune-mediated diseases. As a key technology partner, VEIL.AI has the opportunity to contribute our expertise in next-generation anonymization technology and synthetic data generation to overcome the challenge of secure cross-border data sharing within the WISDOM project. A big thanks to the event organizers at Karolinska Institutet and all participants for making this event a resounding success! We look forward to continuing collaboration with all partners. #WISDOMProject #MultipleSclerosis #RheumatoidArthiritis #MyastheniaGravis #DataPrivacy #DataSharing #DataReuse #CrossBorder #DataAnonymization #SyntheticData #CIMDs #HealthData #EHDS #Stockholm

On June 4-5 VEIL.AI is present at the WISDOM project kick-off in the beautiful Vår Gård Saltsjöbaden in Stockholm archipelago! We are thrilled to be a key technology partner in this groundbreaking initiative that brings together partners from across Europe 🌍 The WISDOM kick-off marks the official start of a transformative journey aimed at improving the management of chronic immune-mediated diseases (CIMDs) through the integration of medical and research data, secure data sharing, and leveraging responsible state-of-the-art artificial intelligence (AI)-mediated models. A key challenge of the WISDOM project is the efficient re-use of the complex biological information from existing clinical registry and research data. This is where VEIL.AI comes into place. VEIL.AI has unique capabilities to provide high-quality, individual-level anonymized data that is secure and compliant with regulations like GDPR and European Health Data Space (EHDS). With years of experience in data anonymization and data-intensive projects, we have been helping customers unlock the full potential of sensitive health data while safeguarding privacy. VEIL.AI's next-generation anonymization and synthetic data generation play a crucial role in the WISDOM project, enabling cross-border data sharing in compliance with regulations - all without compromising on data quality. Our team CTO Timo Miettinen, Senior Research Engineer Kimmo Pääkkönen, Senior Project Manager Anniina Wäyrynen and Bioinformatician Robert Mills of University of Helsinki are present at the kick-off event and eager to have face-to-face discussions in the next couple of days with other key partners of the WISDOM project such as Karolinska Institutet, EMSP - European Multiple Sclerosis Platform, SDU Sønderborg - University of Southern Denmark, University of Eastern Piedmont, University of Copenhagen (Københavns Universitet), University of Cambridge, Centre for Genomic Regulation (CRG), YouHealth AB, Klinikum rechts der Isar der Technischen Universität München and University of Tartu. Thank you to Ingrid Kockum, Alexandra Gyllenberg and the rest of the team at Karolinska Institutet for arranging this kick-off!  #WISDOMProject #DataPrivacy #DataSharing #DataReuse #CrossBorder #DataAnonymization #SyntheticData #CIMDs #HealthData #EHDS #Stockholm

Vor einer Woche war ich in Finnland & will noch ein paar Erkenntnisse mit euch teilen. Natürlich ist das Finnische System nicht mit unserem vergleichbar. Es ist viel zentraler aufgestellt & gleichzeitig ist der staatliche Sektor stark durch unternehmerische Initiativen unterstützt. Diese Verwobenheit kennen wir in Deutschland weniger, unser Gesundheitssystem ist sehr komplex und weniger durch Staat als von Selbstverwaltung geprägt. 3 Dinge, die ich deshalb besonders bemerkenswert fand & für überdenkenswert für Deutschland halte: 👉 Der Europäische Gesundheitsdatenraum kommt und wir sollten ihn als Chance proaktiv angehen. In Finnland erfolgt der Aufbau großer Datenbanken unter staatlicher Trägerschaft. Das sollte auch für uns richtungswesend sein. Ich denke dabei bspw an Projekte wie den Aufbau einer Genomdatenbank in Finnland, an den Einsatz von Künstlicher Intelligenz in der Medizinforschung oder die Anonymisierung von Gesundheitsdaten. Gerade was die Sekundärnutzung von Gesundheitsdaten anbelangt können Finnland und wir uns Piloten vorstellen mit Blick auf den EHDS. Bereits vorhandenen Daten aus den beiden Ländern können geteilt und gemeinsam von Wissenschaftlern und Unternehmen genutzt werden. 👉 Silo-Denken behindert die Digitalisierung. Deshalb müssen Ministerien, nachgeordnete Behörden, Leistungserbringer – alle Akteure konsequent und ressortübergreifend zusammenarbeiten. Dafür benötigen wir mehr multiprofessionelle, agile Teams, die ohne Scheuklappen Lösungen entwickeln. In Finnland stehen z.B. multiprofessionelle Teams zur Verfügung, die die Gesundheit holistisch angehen und schon frühzeitig Präventionsprogramme auf den Einzelnen abstimmen. Arbeitgebende zahlen dies, weil die Krankheitstage damit reduziert werden sollen. 👉 Mit dem finnischen Innovationsfonds Sitra hat Finnland ein Instrument, um in verschiedenen gesellschaftlichen Bereichen Innovationen anzustoßen, u.a. im Bereich der Gesundheitsdaten. Sitra betreibt heute anders als früher keine Förderung von Startups, sondern agiert als Thinktank und Treiber von strukturellen Entwicklungen im staatlichen Bereich (z.B. der Schaffung eines Metadatenkatalogs für Gesundheitsdaten). Die Finanzierung der Aktivitäten von Sitra erfolgt über Erträge, die aus dem Anlagevermögen des Fonds (ca. 1 Mrd. Euro) fließen (derzeit rund 30 Mio. Euro p.a.). Vergleichbare Einrichtungen existieren auch in anderen skandinavischen Ländern, aber auch bei uns in Deutschland wie z.B. SPRINT oder auch die Bayerische Forschungsstiftung. Flächendeckende Lösungen und infrastrukturelle Angebote um Daten im Gesundheitssektor sinnvoll zu verschränken könnten wie in Finnland einen Schwerpunkt bilden. Insgesamt eröffnen der EHDS und grenzübergreifende Kooperation in Europa neue Chancen, die Gesundheitsversorgung der Bevölkerung zu steigern. Durch gemeinsame Projekte und Initiativen können wir es schaffen, die Vision des EHDS umzusetzen und die gesundheitsbezogenen Herausforderungen gemeinschaftlich zu bewältigen.

Our CEO Tuomo Pentikäinen will present the cross-border data collaboration project PHEMS at the upcoming OHDSI (Observational Health Data Sciences & Informatics) European Symposium 2024 in Rotterdam, the Netherlands, June 1st to 3rd! VEIL.AI is an essential partner in PHEMS, which will benefit children’s hospitals and significantly improve pediatric research capabilities in Europe. Read the news here 👉 https://lnkd.in/dN9HU_gF #datacollaboration #datasharing #crossborder #dataanonymization #sensitivedata #healthdata #pediatricresearch #euhospitals #federatedarchitecture